Tsai J F, Chang W Y, Jeng J E, Ho M S, Lin Z Y, Tsai J H
Department of Internal Medicine, Kaohsiung Medical College, Taiwan, Republic of China.
Br J Cancer. 1994 Jun;69(6):1157-9. doi: 10.1038/bjc.1994.227.
Antibody to hepatitis C virus (anti-HCV) was found to be an independent risk factor for hepatocellular carcinoma and raised serum alpha-fetoprotein (AFP) level. In addition, the frequency of raised AFP in patients with anti-HCV was higher than in those without (91.5% vs 65.2%, P = 0.0001).
丙型肝炎病毒抗体(抗-HCV)被发现是肝细胞癌和血清甲胎蛋白(AFP)水平升高的独立危险因素。此外,抗-HCV患者中AFP升高的频率高于无抗-HCV的患者(91.5%对65.2%,P = 0.0001)。